Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines

Cell Immunol. 1986 Jun;100(1):260-7. doi: 10.1016/0008-8749(86)90025-0.

Abstract

Tumor necrosis factor (TNF) exhibits cytotoxic or cytostatic activity on a wide range of animal and human transformed cell lines. Using pure, recombinant human and mouse TNF, we examined the degree of species specificity of the in vitro TNF activity on a variety of human and murine transformed cell lines. This species specificity was studied for the TNF activity alone or in synergism with IFN-gamma. Recombinant human and mouse TNF behave remarkably similarly regarding the in vitro cytolytic/cytostatic activity. However, a certain degree of species-specific preference could be revealed as human cell lines needed a higher concentration of recombinant mouse TNF than of recombinant human TNF to attain a similar effect, while on mouse cells the reverse was true. Also, synergism with IFN-gamma seemed more effective when the target cell was treated with homologous TNF.

MeSH terms

  • Animals
  • Cell Cycle / drug effects
  • Cell Line
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Glycoproteins / pharmacology*
  • Humans
  • In Vitro Techniques
  • Interferon-gamma / pharmacology
  • Mice
  • Recombinant Proteins / pharmacology
  • Species Specificity
  • Tumor Necrosis Factor-alpha

Substances

  • Glycoproteins
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • Interferon-gamma